177 related articles for article (PubMed ID: 22425791)
21. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
[TBL] [Abstract][Full Text] [Related]
22. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
[TBL] [Abstract][Full Text] [Related]
23. Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model.
Jelinski J; Terwilliger A; Green S; Maresso A
Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32393506
[No Abstract] [Full Text] [Related]
24. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.
Winterroth L; Rivera J; Nakouzi AS; Dadachova E; Casadevall A
Infect Immun; 2010 Jun; 78(6):2890-8. PubMed ID: 20385755
[TBL] [Abstract][Full Text] [Related]
25. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.
Hewetson JF; Little SF; Ivins BE; Johnson WM; Pittman PR; Brown JE; Norris SL; Nielsen CJ
Vaccine; 2008 Aug; 26(33):4262-6. PubMed ID: 18586363
[TBL] [Abstract][Full Text] [Related]
26. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
Yan M; Roehrl MH; Basar E; Wang JY
Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
[TBL] [Abstract][Full Text] [Related]
27. Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine.
Gubbins MJ; Schmidt L; Tsang RS; Berry JD; Kabani A; Stewart DI
J Immunoassay Immunochem; 2007; 28(3):213-25. PubMed ID: 17613668
[TBL] [Abstract][Full Text] [Related]
28. Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.
Ngundi MM; Meade BD; Little SF; Quinn CP; Corbett CR; Brady RA; Burns DL
Clin Vaccine Immunol; 2012 May; 19(5):731-9. PubMed ID: 22441391
[TBL] [Abstract][Full Text] [Related]
29. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics.
Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143
[TBL] [Abstract][Full Text] [Related]
30. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
Kelly-Cirino CD; Mantis NJ
Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
[TBL] [Abstract][Full Text] [Related]
32. Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
Verma A; Ngundi MM; Price GA; Takeda K; Yu J; Burns DL
mBio; 2018 Feb; 9(1):. PubMed ID: 29487236
[TBL] [Abstract][Full Text] [Related]
33. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
[TBL] [Abstract][Full Text] [Related]
34. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
35. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
[TBL] [Abstract][Full Text] [Related]
36. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
Gaur R; Gupta PK; Banerjea AC; Singh Y
Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
[TBL] [Abstract][Full Text] [Related]
37. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.
Semenova VA; Schmidt DS; Taylor TH; Li H; Steward-Clark E; Soroka SD; Ballard MM; Quinn CP
Vaccine; 2007 Feb; 25(10):1780-8. PubMed ID: 17229495
[TBL] [Abstract][Full Text] [Related]
38. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.
Devera TS; Aye LM; Lang GA; Joshi SK; Ballard JD; Lang ML
Infect Immun; 2010 Apr; 78(4):1610-7. PubMed ID: 20123711
[TBL] [Abstract][Full Text] [Related]
39. [Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro].
Belova EV; Dubileĭ SA; Kravchenko TB; Kolesnikov AV; Zakharova MIu; Shemiakin IG
Mol Gen Mikrobiol Virusol; 2004; (3):21-6. PubMed ID: 15354937
[TBL] [Abstract][Full Text] [Related]
40. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.
Sloat BR; Cui Z
Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
